ANX Mast Therapeutics, Inc.

SAN DIEGO, Oct. 31 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (AMEX:ANX) today announced that senior management will make presentations at three conferences during the week of November 6: * Evan M. Levine, chief executive officer, will present at the Rodman and Renshaw 8th Annual Healthcare Conference on Tuesday, November 7 at 10:15 a.m. Eastern Time. This conference will be held at the Palace Hotel in New York. For more information about this conference visit http://www.rodmanandrenshaw.com/Conferences.asp?CID=conf19. * Evan Levine will also present at the CIBC World Markets 17th Annual Healthcare Conference on Tuesday, November 7 at 1:50 p.m. Eastern Time. This conference will be held at The Waldorf-Astoria Hotel in New York. For more information about this conference visit http://conferences.cibcwm.com/health06/. * Brian M. Culley, senior vice president of business development, will present at the BIO-Europe 2006 12th Annual International Partnering Conference on Wednesday, November 8 at 10:15 a.m. Central European Time (4:15 a.m. Eastern Time). This conference will be held in Dusseldorf, Germany. For more information on this conference visit http://www.ebdgroup.com/bioeurope/index.htm. A live slide and audio webcast of Mr. Levine's presentation at the Rodman and Renshaw 8th Annual Healthcare Conference will be available via the Internet by visiting the "Investors" section of the Company's Web site at http://www.adventrx.com/. The presentation and link to the archived webcast will be available on the ADVENTRX Web site for 14 days. About ADVENTRX Pharmaceuticals ADVENTRX Pharmaceuticals is a biopharmaceutical research and development company focused on commercializing low development risk pharmaceuticals for cancer and infectious disease that enhance the efficacy and/or safety of existing therapies. More information can be found on the Company's Web site at http://www.adventrx.com/. Forward Looking Statement ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors that, if they do not materialize or prove to be accurate, could cause ADVENTRX's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties that could cause actual results to differ materially include, but are not limited to: uncertainties inherent in the drug development process; the timing and success of clinical trials; the validity of research results; the receipt of necessary approvals from the FDA and other regulatory agencies; and other risks and uncertainties more fully described in ADVENTRX's press releases and periodic filings with the Securities and Exchange Commission. ADVENTRX's public filings with the Securities and Exchange Commission are available at http://www.sec.gov/. ADVENTRX does not intend to update any forward-looking statement, including as set forth in this press release, to reflect events or circumstances arising after the date on which it was made. DATASOURCE: ADVENTRX Pharmaceuticals CONTACT: Andrea Lynn of ADVENTRX Pharmaceuticals, +1-858-552-0866 Web site: http://www.adventrx.com/ Company News On-Call: http://www.prnewswire.com/comp/920134.html

Copyright